Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents

Elena González-Hernández, Rubén Aparicio, Mercedes Garayoa, María J. Montero, María A. Sevilla, Concepción Pérez‐Melero

MedChemComm · 2019 · 15 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

4-Aryldihydropyrimidine-2-thiones are proposed as potential antitumour dual agents, both as Eg5 inhibitors and L-type calcium channel blockers.

References

26